Pasta is an easy, affordable meal that can be enjoyed in hundreds of ways. However, there are some potential health side ...

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

Probability of Remaining Event-Free at 24 Months by Kaplan-Meier Analysis After Achieving Complete Response at Three Months (79.6%) PRINCETON, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma ...

This week in oncology, the FDA expanded the treatment landscape for platinum-resistant ovarian cancer with a new approval, and significant clinical data emerged regarding novel in ...

As cancer care becomes both more advanced and more specialized, options in rural areas have shrunk.

Crackers might be a fine addition to many meals, but if you're not careful, certain crackers could lead to rather serious ...

Johnson & Johnson (NYSE:JNJ) reported first in human Phase 1 results for an extended release erdafitinib delivery system in ...

Accelerated water-bath thawing, completed in about 25 minutes, may help streamline clinical workflows and support efficient patient management -- Label update includes data showing that product ...

Nadofaragene firadenovec-vncg is the only FDA-approved nonreplicating intravesical gene therapy for high-risk ...

Relmada Therapeutics (RLMD) stock gains as Piper Sandler starts coverage with an overweight recommendation, citing its ...

Ferring Pharmaceuticals’ Adstiladrin receives US FDA label update to speed up thaw time: Parsippany, New Jersey Friday, March 27, 2026, 12:00 Hrs [IST] Ferring Pharmaceuticals a ...

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...